Campbell David Alan — SEC Form 4 filings
SEC reporting owner CIK 1864158. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-31.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-09-27 to 2026-07-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 7 filings — 128,072 shares, $6,606,717 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 25,000 shares @ $56.19 ($1,404,805) in Janux Therapeutics, Inc., filed 2024-12-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | President and CEO, Director | 10 | — | 11 legs · 128,072 sh · $6,606,717 | 7 |
Form 4 filings — Campbell David Alan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-31 | 4 | Janux Therapeutics, Inc. (JANX) | Gift (G): 123,840 @ $0 | EDGAR |
| 2026-07-10 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 7,000 @ $4.21 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Janux Therapeutics, Inc. (JANX) | Sale (S): 8,072 @ $13.73 · Grant/award (A): 96,600 @ $0 · Grant/award (A): 338,100 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Janux Therapeutics, Inc. (JANX) | Sale (S): 5,000 @ $60.00 | EDGAR |
| 2025-01-03 | 4 | Janux Therapeutics, Inc. (JANX) | Grant/award (A): 81,000 @ $0 · Grant/award (A): 283,500 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | Janux Therapeutics, Inc. (JANX) | Sale (S): 25,000 @ $56.19 | EDGAR |
| 2024-12-03 | 4 | Janux Therapeutics, Inc. (JANX) | Sale (S): 15,000 @ $67 | EDGAR |
| 2024-11-27 | 4 | Janux Therapeutics, Inc. (JANX) | Sale (S): 18,281 @ $51.43 · Sale (S): 6,719 @ $52.04 | EDGAR |
| 2024-10-30 | 4 | Janux Therapeutics, Inc. (JANX) | Sale (S): 13,897 @ $53.22 · Sale (S): 11,103 @ $53.94 | EDGAR |
| 2024-09-27 | 4 | Janux Therapeutics, Inc. (JANX) | Sale (S): 18,957 @ $46.09 · Sale (S): 5,248 @ $46.85 · Sale (S): 795 @ $47.84 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1864158 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →